Alvotech and Advanz Pharma have inked a deal to expand their commercial partnership to cover three additional biosimilar ...

The FDA designates 2 biosimilars as interchangeable, enhancing access to treatments for inflammatory diseases and multiple ...

Trans-Tasman drug developer Aft Pharmaceuticals is targeting lucrative niche diseases its Big Pharma rivals have ignored ...

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27, 2025 ...

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27, 2025 – Zealand ...

European shares were higher on Monday as investors reacted to U.S. President Donald Trump delaying the roll out of 50% tariffs on the European Union. European autos stocks rebounded from a 3% loss ...

Elsewhere, Zealand Pharma climbed to the top of the Stoxx 600 with shares up 10%. It came after Cantor Fitzgerald maintained its overweight position on the stock, with analyst Prakhar Agrawal ...

As New Zealand restarted free trade negotiations with the South Asian nation, is it time to re-examine the potential for pharmaceutical trade? According to the Ministry of Foreign Affairs and Trade, ...